Acute liver failure after treatment with nefazodone

Digestive Diseases and Sciences

Volumn 44, Issue 12, 1999, Pages 2577-2579

  Lucena, M Isabel ^a,b   Andrade, Raul J ^a   Gomez Outes, Antonio ^a   Rubio, Manuel ^a   Cabello, Maria R ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Department of Clinical Pharmacology   (Spain)

Author keywords

Acute liver failure; Antidepressants; Nefazodone

Indexed keywords

NEFAZODONE;

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; JAUNDICE; LAPAROTOMY; LIVER BIOPSY; LIVER FAILURE; LIVER NECROSIS; PRIORITY JOURNAL;

EID: 0033402602     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026620029470     Document Type: Article

References (9)

1. 1. Nefazodone: A better tolerated option than TCAs for major depression. Drugs Ther Perspect 10:1-7, 1997
2. 2. Zimmerman HJ: Hepatotoxicity. Dis Month 39:675-787, 1993
3. 3. Cosme A, Barrio J, Lobo C, Gil Y, Castiella A, Arenas JT: Acute cholestasis by fluoxetine. Am J Gastroenterol 91:2449-2450, 1996
4. 4. Lee WM: Acute liver failure. N Engl J Med 329:1862-1872, 1993
5. 5. Parrel GC: Pathogenesis of drug-induced liver disease. In AASLD Postgraduate Course. Liver Injury Update: Clinical Implications and Mechanism Role of Cells of the Liver. 1997, pp 37-47
6. 6. Caccia S: Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Clin Pharmacokinet 34:281-302, 1998
7. 7. Barbhaiya RH, Buch AB, Greene DS: Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan. Br J Clin Pharmacol 42:573-581, 1996
8. 8. Chu AG, Gunsolly BL, Summers RW, Alexander B, McChesney C, Tanna VL: Trazodone and liver toxicity. Ann Intern Med 99:128-129, 1983
9. 9. Robinson DS, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA, Marcus RN: The safety profile of nefazodone. J Clin Psychiatry 57(suppl 2):31-38, 1996